Literature DB >> 23929481

Draft Genome Sequence of Strain SA_ST125_MupR of Methicillin-Resistant Staphylococcus aureus ST125, a Major Clone in Spain.

Laura Barrado1, Esther Viedma, Ana Vindel, Joaquín R Otero, Fernando Chaves.   

Abstract

Here, we report the draft genome sequence of a methicillin-resistant Staphylococcus aureus (MRSA) strain with high-level mupirocin resistance (SA_ST125_MupR), isolated from a patient with recurrent bacteremia. This strain belonged to sequence type ST125, which was responsible for more than 50% of the health care-associated infections caused by MRSA in Spain.

Entities:  

Year:  2013        PMID: 23929481      PMCID: PMC3738897          DOI: 10.1128/genomeA.00588-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Methicillin-resistant Staphylococcus aureus (MRSA) is among the most frequently identified antimicrobial drug-resistant pathogens worldwide. It has been demonstrated that some lineages are ecologically highly successful and that most isolates belong to pandemic clones (1). In Spain, S. aureus sequence type ST125 continues to be responsible for more than half of the nosocomial MRSA infections (2). With increasing pressure to prevent MRSA infection, it is possible that there will be increased use of mupirocin for nasal decolonization of MRSA (3), which will be reflected in increased rates of resistance (4). High-level mupirocin resistance (Hi-MupR) (MICs of ≥512 μg/ml) is mediated by acquisition of a novel isoleucyl-tRNA synthetase gene (mupA or ileS2) on a transferable plasmid, which could carry multiple resistance determinants for other classes of antimicrobial agents (3). S. aureus ST125 was the most prevalent MRSA strain (83.3%) in our institution. We detected 8.8% Hi-MupR among MRSA isolates, and most of this resistance was focused on the ST125 clone (5). The S. aureus SA_ST125_MupR strain was isolated from an adult patient with recurrent bacteremia. This strain was characterized as pulsed-field gel electrophoresis pattern type E8, spa type t1399, agr type II, and staphylococcal cassette chromosome mec element (SCCmec) type IVc (6). Genomic DNA was extracted from an overnight culture using the DNeasy blood and tissue kit (Qiagen) after addition of lysostaphin (100 μg/ml) and incubation at 37°C for 2 h. The S. aureus SA_ST125_MupR genome was sequenced by using the 454 GS-Junior platform (Roche), generating 196,055 reads, for a total of 91,441,914 bp, with 29-fold average coverage. With the Newbler Assembler v2.7 (Roche), the obtained sequences were de novo assembled into 49 contigs with an N50 contig size of 192,317 nucleotides and a total length of 2,852,031 bp. The average G+C content was 32.7%. Sequences were annotated using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (PGGAP) (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/), yielding a total of 2,757 genes, 2,664 coding DNA sequence (CDS) genes, 26 pseudogenes, 58 tRNAs, and 9 rRNAs. Furthermore, the Rapid Annotations using Subsystems Technology (RAST) (http://rast.nmpdr.org) server (7) and Comprehensive Antibiotic Resistance Database (CARD) (http://arpcard.mcmaster.ca) (8) were used. There were genes related to antibiotic resistance and toxic compounds. These included efflux pumps (ATP-binding cassette [ABC] transporter, major facilitator superfamily, small multidrug resistance) potentially carrying resistance to a wide range of antimicrobials (fluoroquinolones, tetracyclines, and macrolides), and genes associated with specific resistance to β-lactams (mecA, mecR1, mprF, blaZ, blaI, and blaR), aminoglycosides (phosphotransferases, adenyltransferases, and nucleotidyltransferases), macrolides/lincosamides/streptogramins (mph, macB), fosfomycin (fosB), tetracycline (tetM), rifampin (dnaA), glycopeptides (bleO), and mupirocin (ileS, ileS2), as well as resistance determinants to arsenic, cadmium, cobalt, mercury, and zinc. The ileS2 gene was located on a plasmid which was partially sequenced, giving a final size of ~58 kb, and it harbored other genes associated with resistance to β-lactams and macrolides. Overall, the availability of the present genome sequences facilitates further comparative genomic and bioinformatic analysis in S. aureus populations and may also provide insights into the genetic background for the success of this nosocomial lineage.

Nucleotide sequence accession number.

This whole-genome shotgun project has been deposited at GenBank under the accession number ASTH00000000.
  8 in total

1.  Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002.

Authors:  A Vindel; P Trincado; E Gómez; R Cabrera; T Boquete; C Solá; S Valdezate; J A Saez-Nieto
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain.

Authors:  Maria Daskalaki; Joaquin R Otero; Fernando Chaves
Journal:  J Antimicrob Chemother       Date:  2009-02-17       Impact factor: 5.790

3.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

4.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mark C Enright; D Ashley Robinson; Gaynor Randle; Edward J Feil; Hajo Grundmann; Brian G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.

Authors:  Marine Desroches; Julien Potier; Frédéric Laurent; Anne-Sophie Bourrel; Florence Doucet-Populaire; Jean-Winoc Decousser
Journal:  J Antimicrob Chemother       Date:  2013-03-27       Impact factor: 5.790

Review 6.  Mupirocin resistance.

Authors:  Jean B Patel; Rachel J Gorwitz; John A Jernigan
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

7.  Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods.

Authors:  Ana Vindel; Oscar Cuevas; Emilia Cercenado; Carmen Marcos; Verónica Bautista; Carol Castellares; Pilar Trincado; Teresa Boquete; Maria Pérez-Vázquez; Mercedes Marín; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

8.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  8 in total
  1 in total

1.  Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.

Authors:  Juan de Dios Caballero; María Dolores Pastor; Ana Vindel; Luis Máiz; Genoveva Yagüe; Carme Salvador; Marta Cobo; María-Isabel Morosini; Rosa del Campo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.